Home › Funds › Marshall Wace › CTKB
Marshall Wace position in CTKB
CYTEK BIOSCIENCES INC · Industrials
Latest position (Q2 2026)441.70K sh
Reported value held$1.96M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 7.16K | $117.00K | New |
| Q2 2022 | 54.10K | $582.00K | New |
| Q1 2024 | 68.59K | $460.25K | New |
| Q2 2025 | 261.35K | $888.60K | New |
| Q3 2025 | 134.29K | $465.98K | Reduce |
| Q2 2026 | 441.70K | $1.96M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTKB
- BlackRock Inc 9.58M sh · $42.43M · Q2 2026
- Millennium Management 9.34M sh · $41.37M · Q2 2026
- Vanguard Group 7.48M sh · $37.75M · Q4 2025
- Hillhouse Capital (HHLR Advisors) 6.66M sh · $29.49M · Q2 2026
- Geode Capital Management 3.06M sh · $13.56M · Q2 2026
- Goldman Sachs Group 2.17M sh · $9.60M · Q2 2026
- Royce & Associates 2.08M sh · $9.22M · Q2 2026
- Bank of America Corp 1.32M sh · $5.83M · Q2 2026
- Charles Schwab Investment Management 1.07M sh · $4.75M · Q2 2026
- Northern Trust Corp 1.00M sh · $4.44M · Q2 2026
- Arrowstreet Capital 973.83K sh · $4.31M · Q2 2026
- AQR Capital Management 813.97K sh · $3.61M · Q2 2026